Picture of Chimerix logo

CMRX — Chimerix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Chimerix Inc reports results for the quarter ended in March - Earnings Summary

* Chimerix Inc  CMRX.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 25
cents per share.
    * Revenue rose 1,786.7% to $283.00 thousand from a year ago;
analysts expected $100.00 thousand. 
    * Chimerix Inc's reported EPS for the quarter was a loss
of 24
cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Chimerix Inc shares had fallen by 10.3% this quarter and
lost 39.2% so far this year.
    * The company reported a quarterly loss of $21.37 million.
    * Wall Street's median 12-month price target for Chimerix
Inc is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.25          -0.24          Beat
 Dec. 31 2022      -0.24          -0.24          Met
 Sep. 30 2022      2.14           2.75           Beat
 Jun. 30 2022      -0.24          -0.27          Missed

Recent news on Chimerix

See all news